SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck

Completed · Phase 2

Conditions studied: Carcinoma of Unknown Primary, Head and Neck Cancer, Non-melanomatous Skin Cancer

In brief

RATIONALE: SU5416 may stop the growth of cancer cells by stopping blood flow to the tumor. PURPOSE: Phase II trial to study the effectiveness of SU5416 in treating patients who have advanced or recurrent cancer of the head and neck.

Key facts

Study ID

NCT00006361

Run by

Memorial Sloan Kettering Cancer Center

Starts

2000-12-01

Last updated by the study team

2009-12-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Memorial Sloan-Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.